Therapeutic or non-therapeutic use of protozoans of the willaertia genus as a fungistatic and / or fungicide

IN606788BActive Publication Date: 2026-10-23AMOEBA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
IN202017004203
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Priority Date
2017-08-10
Filing Date
2020-01-30
Publication Date
2026-10-23
Estimated Expiration
2038-08-09

AI Technical Summary

Technical Problem

Current fungicides are inefficient and toxic, leading to environmental contamination and health hazards, with widespread use resulting in resistant strains and decreased effectiveness, necessitating the development of natural, broad-spectrum antifungal agents that are safe for humans and the environment.

Method used

The use of protozoa from the genus Willaertia, particularly Willaertia magna in live, dead, or cell lysate form, exhibits fungistatic and fungicidal activity, effectively targeting fungal spores and infections in plants and humans, offering a non-toxic and environmentally friendly alternative.

Benefits of technology

Willaertia magna protozoa demonstrate significant inhibition of fungal germination and growth, providing effective control of fungal diseases in plants and humans with reduced environmental impact and lower production costs, maintaining efficacy against resistant strains.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to a therapeutic or non-therapeutic use of protozoans, for examples protozoans of the Willaertia magna amoeba species, as a fungistatic and / or fungicide.
Need to check novelty before this filing date? Find Prior Art

Description

The invention relates to the use of protozoa Willaertia including Willaertia magna as fungistatic and / or fungicide.ContextThe fungi (yeasts and molds) are responsible for many diseases affecting both plants, animals and humans.Many fungicides have been developed to eliminate fungi or limit their development and thus treat and / or prevent diseases caused by fungi.However, the use of these compounds is often not optimal either in efficiency or in terms of toxicity to humans or the environment.Indeed, the massive use, agricultural or not pesticides or chemical antifungal raises many health and environmental problems. In environmental terms, there is an increasing contamination of soil and groundwater by molecules contained in plant protection products. These pollutants can cause disturbance to contaminated ecosystems, their potential toxicological effects on non-target organisms. Besides the environmental risks, hazards related to the use and exposure to pesticides are well documented and are subject to a warning from the World Health Organization (WHO). Concerning the treatment of fungal infections, it is necessary to provide an antifungal compound that is non-toxic to humans. In addition, the widespread use of these compounds results in the appearance of strains resistant to these products. The population trends led eventually to the products effectiveness drops of up to a total loss.The awareness of environmental and health risks caused by the massive use of chemical pesticides has contributed to promote recent years the development of demand for antifungal natural products, including the toxicological and environmental impact is low.These less harmful to humans and the environment also have the advantage of ease of use, as they benefit from less regulation.There is therefore a significant need for the development of new natural fungicide compositions, broad spectrum that are both effective, simple to implement, and whose production costs are controlled.It would also be advantageous that such compositions can act on the spores to provide optimum efficiency.RésuméIn this context, the inventors have demonstrated, entirely surprisingly, that the protozoa of the genus Willaertia, including protozoa of the species amoebic Willaertia magna live form and / or in dead form and / or as cell lysate, possess fungistatic activity and / or fungicide, particularly by acting on the spores.A first aspect of the present disclosure is the use of non-therapeutic protozoa of the genus Willaertia, for example of the species Willaertia magna in a live or dead form, and / or as a cell lysate, as fungistatic and / or fungicidal .A second aspect of the present disclosure is the use of protozoa of the genus Willaertia, for example of the species Willaertia magna, the live form and / or dead and / or as a cell lysate for use as a medicament antimycotic.A third aspect of the present disclosure is a plant protection product comprising an effective amount of protozoa of the species Willaertia magna, the live form and / or inactive and / or as a cell lysate.A fourth aspect is a pharmaceutical product comprising an effective amount of protozoa of the species Willaertia magna, the live form and / or inactive and / or as a cell lysate.According to the present disclosure, protozoa of the genus Willaertia including species Willaertia magna live form and / or dead and / or in a cell lysate, can be used for preventive or curative.Protozoa of the species Willaertia magna, a live or dead form, can be used alone or advantageously in combination with other protozoa, including amoebic protozoa of the genus Solumitris, cercozoa of protozoa Cercomonas kind or cercozoa protozoa of the genus Paracercomonas.Preferably, protozoa used in the context of the present disclosure correspond to strain Willaertia magna filed on 21 August 2006 under the number PTA-7824 with the ATCC or the strain Willaertia magna filed on 21 August 2006 under number PTA-7825 in the ATCC, these two strains having been initially registered in the names of the NATIONAL CENTER fOR SCIENTIFIC RESEARCH (CNRS) - 3 rue Michel Ange - 75794 PARIS CEDEX 16 / France and UNIVERSITY LYON 1 CLAUDE BERNARD - 43 Boulevard du 11 November 1918-69622 Villeurbanne Cedex / France. Said deposited strains are also described in the publication of PCT international application WO2008 / 043969.As used within this disclosure, the term "plant" and "plant" means as whole plants that isolated parts of these plants such as leaves, fruits, flowers, seeds, seeds, trunk, the roots, stems.As used within this disclosure, the term "mushroom" refers to unicellular or multicellular fungi, including yeasts and molds, as spores or as mycelium.As used in the context of the present disclosure, the term "plant protection product" refers to a preparation or a mixture of substances intendedto protect plants against one or more pests,and / or prevent the action of organisms harmful to plants and / or perform an action on the vital processes of plants (since it is not a question of nutrients)and / or to ensure the conservation of plant products.As used within this disclosure, the term "living form" means the metabolically active vegetative form of the protozoan.As used in the context of the present disclosure, the term "dead form" refers to a metabolically inactive form of the protozoan, which has been inactivated by a mechanical, physical, thermal or chemical, e.g. osmotic shock, heat shock, ultrasound, or under mechanical stress type centrifugation for example. The "dead form" may contain whole dead cells of the microorganism or the cell lysate, or a mixture of dead cells and whole cell lysate. A lysate commonly denotes a material obtained after the destruction or dissolution of biological cells by a phenomenon called cell lysis thereby causing the release of the intracellular biological constituents naturally contained in the cells of the microorganism considered.Differentiation between living cells, dead cells and lysate may in particular be done by microscopic observation with staining with a marker of non-viability as trypan blue (CAS: 72-57-1), which indicates dead cells.The non-therapeutic use is, in particular, multiple applications:- to fight against the proliferation of plant pathogenic fungi, preferably for the treatment of fungal diseases of grapes, cereals, potatoes, fruit trees and vegetable crops, even more preferably for the treatment of diseases fungal chosen from powdery mildew, downy mildew of the vine, septoria and Fusarium on cereals Phelminthosporiose cereal mildew and early blight of potato, apple scab, Sclerotinia rapeseed and of vegetable crops and a combination thereof.- for disinfecting networks (other than lathes aero -réfrigérantes) of air handling units;to fight against fungal contaminations and / or the formation of fungal slimes in food, processing equipment / food production, processing plants / food production, the surfaces coming into contact with foodstuffs;to fight against fungal contaminations and / or the formation of fungal slimes in cosmetics, processing equipment / production of cosmetics, processing plants / production of cosmetic products, the surfaces coming into contact with cosmetic products;The use as medicament antimycotic find particular application in the treatment of infections caused by fungi selected from Aspergillus, Candida, U. botrytis, A.niger, P.variotii, A.alternata, and a combination thereof, of preferably Candida, still more preferably Candida albicans.The use also finds application in the treatment of nosocomial infections caused by fungi, especially respiratory diseases.Preferably, protozoa of the genus Willaertia, in particular of the species Willaertia magna in a live or dead form (such as a cell lysate), or a mixture of live and dead forms, are used to fight against a fungus selected from division Ascomycetes, more preferably from the class of Sordariomycetes, eurotiomycetes, Dothideomycetes, Saccharomycetes, Leotiomycetes, oomycetes and a combination thereof, more preferably from the genus Botrytis, Erysiphe, Fusarium, Penicillium, Plasmopara, Phytophthora, Chaetomium, Trichoderma, Aspergillus, Alternaria, Candida, Ulocladium, Epicoccum, Cladosporium and a combination of these and even more preferably from B. cinerea, E. necator, F. solani, C. globosum, P. chrysogenum, P. expansum, P. viticola, P. infestans,T. viride, T. harzianum, A. fumigatus, A.alternata, A.flavus, P. variotii, A.niger, C. albicans, U. botrytis, E. nigrum, B. cinerea, P. roqueforti, C. cladosporioides, chevalieri E., A. pullulans et une combinaison de ceux-ci.In a particular embodiment, protozoa of the species Willaertia magna are used either in a live form, or in dead form (such as a cell lysate), or a mixture of live and dead forms. In a particular embodiment, the mixture used comprises 50% or more of protozoa in dead form, such as a cell lysate, e.g. 60% or more, 70%> or more, 80%> or more, 90%> or more, 95% or more ofprotozoa in dead form (relative to the total number of pre-inactivation protozoa), particularly in the form of cell lysate.In a particular embodiment, protozoa of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, are used to fight against fungal diseases of plants. Preferably the plants are selected from grasses, broadleaf weeds, annuals, biennials and perennials, vegetable plants or harvested vegetables, fruit plants or trees or harvested fruit, cereals, oilseeds, protein crops, woody plants, and are in particular selected from plants or produced from potato, sugar beet, sugarcane, tobacco, grapevine, wheat, rape, barley, rice, maize, sorghum, millet, soybean, bean, tomato, cucumber lettuce, strawberry,In a particular embodiment, protozoa of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, are used to fight against fungi affecting surfaces, materials, equipment and / or ventilation systems.In a particular embodiment, protozoa of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, are used to fight against fungi that affect human or animal health.In another particular embodiment, the protozoa of the genusWillaertia, in particular of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, are used to fight against F . solani for the treatment of fungal diseases of plants (cereals and maize).In another particular embodiment, the protozoa of the genusWillaertia, in particular of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, are used to fight against C . globosum for the treatment of fungal diseases of plants, preferably affecting grain or rice or for the treatment of infections of cellulose products such as paper and building materials.In another particular embodiment, protozoa of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate are used against P. viticola for the treatment of fungal diseases of plants, preferably affecting the vine.In another particular embodiment, protozoa of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate are used against P. infestans for the treatment of fungal diseases of plants, preferably affecting the potato.In another particular embodiment, protozoa of the genus Willaertia, in particular of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, are used to fight against the mold Penicillium genus as P. chrysogenum, the genus Aspergillus such as Aspergillus Niger, or Cladosporium Cladosporium cladosporioides as for the treatment of contamination of indoor environments such as walls, materials , equipment and ventilation systems, etc.In another particular embodiment, protozoa of the genus Willaertia, in particular of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, were used against T. viride and / or T. harzianum for the treatment of contamination of food and indoor environments such as walls, materials, equipment and ventilation systems, etc.In another particular embodiment, protozoa of the genus Willaertia, in particular of the species Willaertia magna in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, are used to fight against A. fumigatus for the treatment of nosocomial infections, particularly respiratory diseases.In another particular embodiment, protozoa of the genus Willaertia, in particular of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, are used to fight against A.alternata for the treatment of fungal diseases of plants, preferably early blight of potato or the treatment of cutaneous lesions, fungal infections and infections of the upper respiratory tract in the man.In another particular embodiment, the protozoa of the genusWillaertia, in particular of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, are used to fight against P . variotii for treating fungal infections and / or the formation of fungal biofilms in food, preferably cereal or for treatment of fungal infections, pneumonia, sinusitis in humans.In another particular embodiment, protozoa of the genus Willaertia, in particular of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, are used to fight against A.niger for treating fungal infections and / or the formation of fungal biofilms in food, indoor environments such as walls, materials, equipment and systems ventilation, etc. or for the treatment of fungal infections of the inner ear or pulmonary aspergillosis in humans.In another particular embodiment, the protozoa of the genus Willaertia including species Willaertia magna, a live or dead form, are used to fight against C. albicans for the treatment of fungal infections in humans.In another particular embodiment, the protozoa of the genusWillaertia, in particular of the species Willaertia magna in a live or dead form, are used to fight against U. botrytis for the treatment of fungal diseases of plants, the treatment of fungal infections and / or the formation ofOrganic fungal films in the food and for the treatment of onychomycosis.In another particular embodiment, the protozoa of the genus Willaertia including species Willaertia magna, a live or dead form, are used to fight against E. nigrum or A. pullulans to treat fungal infections and / or formation of fungal biofilms in food or cosmetics or contamination of indoor environments such as walls, materials, equipment and ventilation systems, etc.In another particular embodiment, the protozoa of the genusWillaertia, in particular of the species Willaertia magna in a live or dead form, are used to fight against A. flavus, P. roqueforti, B. cinerea, C. cladosporioides or E. chevalieri for the treatment of fungal infections and / or formation of fungal biofilms in food or cosmetics.The present disclosure also relates to a plant protection composition comprising an effective amount of protozoa of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate.In a particular embodiment, the plant protection composition contains an effective amount of protozoa of the species Willaertia magna form of cell lysate.In a particular embodiment, the plant protection composition also comprises one or more formulating agents, in particular water, and, if appropriate, one or more supplementary builders.In a particular embodiment, the plant protection composition is a dry solid formulation composition, preferably in dried or lyophilized form. The plant protection composition is in dry form to be reconstituted with a reconstituting solvent before use to be ready for use. The reconstitution solvent is preferably water.In another particular embodiment, the plant protection composition is a concentrated liquid formulation composition. The plant protection composition in concentrated liquid form is intended to bediluted with a dilution solvent before use to be ready for use. The dilution solvent is preferably water.In another particular embodiment, the plant protection composition is a liquid formulation composition directly ready for use.The plant protection composition described above, in its final form ready to use, can be applied to plants in different ways and according to different treatment programs. In particular, the application of plant protection composition can be before or after harvesting the leaves, soil, flowers, branches, stems, trunk, roots and / or fruits. The application of the plant protection composition is preferably by spraying. The application of plant protection composition may also be in admixture with other plant protection products, fertilizers, to irrigation water or another.For non-therapeutic uses, protozoa of the species Willaertia magna, a live or dead form, can be directly contacted on processing equipment / production and surfaces that come into contact with foodstuffs or cosmetics or the plants to be treated. The treatment can be done for example by spraying, for example in the form of an aqueous solution in aerosol. Such protozoa can therefore also be used in combination with other disinfecting agents and / or pesticides.The present disclosure also relates to a pharmaceutical composition comprising an effective amount of protozoa of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate, as antimycotic and a pharmaceutically acceptable carrier. Said pharmaceutical composition can in particular be a dressing with active substance, a poultice, a medicated plaster, a gel, a paste, a lotion, a foam, an oil, an emulsion, aqueous solution, aqueous suspension, cream, ointment, powder or spray applied to the skin or mucous membranes.For use as antimycotic drug, protozoa, in particular of the species Willaertia magna, in a live form or dead form or as a cell lysate, or in admixture of living forms, and / ordead forms and / or cell lysate, can be applied to the lesions topically to the skin or mucous membranes (e.g. as a cream, ointment, spray or powder for application to the skin or mucosa, typically vaginal or anal mucosa).The disclosure also relates to a pharmaceutical composition comprising an effective amount of protozoa such as antimycotic and a pharmaceutically acceptable carrier. Said pharmaceutical composition can in particular be a dressing with active substance, a poultice, a medicated plaster, a gel, a paste, a lotion, a foam, an oil, an emulsion, aqueous solution, aqueous suspension, cream, ointment, powder or spray applied to the skin or mucous membranes.Another object of the present disclosure is a method of controlling against the growth of fungi, with the exception of the treatment methods applied to the human or animal body, comprising a protozoa contacting step of the present case Willaertia magna under living form or dead form or as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate with said fungi.Description of figuresFigure 1: Effect on amoeba of germination of B. cinerea. microplate assays in the presence of spores of B. cinerea without amoebae. Observation after 24 hours of incubation. susceptible strains: B05.10 and M421. Strain resistant: M426. (Fungicide inhibitor of respiration)Figure 2: Effect on amoeba of germination of B. cinerea. microplate assays in the presence of spores of B. cinerea + 500 amoebae in MC medium and spores of B. cinerea +. susceptible strains: B05.10 and M421. Strain resistant: M426. (Fungicide inhibitor of respiration). 50000 MC amoebae in the middle. Observation after 24 hours of incubation.Figure 3: Effect of the culture medium (CM) on the germination of B. cinerea susceptible strains. microplate assays in the presence of spores of B. cinerea + culture medium (MC). susceptible strains: B05.10 and M421. Observation after 24 hours of incubation.ExamplesThe following examples illustrate the invention but have no limiting character.Example 1: qPCR Analysis of the fungal DNA of the fungus-Willaertia interactions of 19 strains.The tests of interaction of 19 fungal strains (Table 1) were carried out by placing the spores in contact with the amoeba "Willaertia magna" ATCC PTA-7824 in a ratio amoeba / spore amoebae = 10 / spores, sclerosis 24 well.In a first plate, single spores of each strain were incubated under the same conditions (in 2 ml MEAC). After contact 3H, the solution is centrifuged at 14,000 rpm for 5 minutes. The supernatant is then discarded and the pellet taken up in 200μ1 for DNA extraction.For the tests to 24H made in a second plate, the supernatant is removed directly from the wells after 24 hours and "mixtures Spores amoebae" are included in 200μ1 to extract DNA. Followed by a microscopic observation is performed at each step. A DNA extraction is carried out on the samples (200μ1) using the kit "NucleoSpin Plant II - Macherey-Nagel" according to manufacturer's instructions after a grinding step with fine sand.QPCR amplification of DNA alone and fungi complex Willaertia- champignos was carried out on a Biorad CFX96-device. Quantization is performed in a final volume of 20μ1 containing DNA 5μ1, primers (300 nM) and 10μΙ of SybrGreen-Mix. The following program was used: denaturation step 95 ° C for 10 minutes with an amplification step "95 ° C for 15 seconds + 60 ° C for 1 minute" of 35 cycles.The tests on 19 strains of fungi are made according to the validated protocol in the previous step. The plates are observed under a microscope before starting the molecular analysis. The results are qPCR curves obtained in triplicate for each condition (spores-3H, 24H-spores, spore-amibe3H and spore- amibe24H). Since the qPCR analysis using universal primers, a range of the fungus P.chrysogenum was used to approximate the amount of amplified DNA for each test. These data allow to evaluate the transition from stage spore mycelium in control without amoeba and the degree of inhibition of germination in the presence of amoeba.Results and conclusion: Table 1: qPCR amplification difference between the tests carried out on the only spores (gap between 3 and 24 hours) or in interaction with amoebae after contact 24H. Acq (3H-24H): difference in number of cycles between the spores to 3H and 24H. Acq (T24H- Willaertia24H): difference in number of cycles between single spores (T24h) and in the presence of amoebae (Amoeba 24H) after 24 hours of incubation.corresponding to tests "mushroom amoeba-24H" (low fungal biomass) are higher than those of control runs to 24H (high biomass).QPCR analysis helped quantify fungal bio mass and differentiate fungal development stages and show fungistatic and / or fungicidal of 19 treated strains with very important differences. The difference in number of Cq cycles between the two tests with and without amoeba is very important and in some cases exceeds 10 cycles. These results reflect the presence of a very low fungal biomass in the presence of amoebas after 24 hours of incubation following the inhibition of spore germination. The difference between the spore stage 3H and mycelium developed after 24H is clearly proven by the difference between the amplification spores 3H and 24H of the strains tested.Example 2: Study of the effect Willaertia masna growth of Botrytis cinerea.Principle: The tests were inspired by the tests used in the laboratory to evaluate the efficacy of molecules conventional fungicides. The effect of the amoeba Willaertia magna (strain ATCC PTA-7824) on spore germination of B. cinerea is analyzed by contacting different concentrations of amoebae with spores of the fungus. After 24 hours of incubation, spore germination of B. cinerea in the presence of amoeba is compared to the control without amoebae.Protocol: The strains of B. cinerea were maintained in culture medium(Based on oatmeal) as a light alternation of day-UV (12H / 12H) at 21 ° C. Strains, sensitive or resistant to a fungicide phenotypes belonging to inhibitors of cellular respiration. References of strains tested are: strain B05.10 (sensitive), M421 (sensible isolated from the field) and M426 (resistant insulated from the field).To test the effect of the amoeba Willaertia magna on the germination of B. cinerea conidia, spores of the fungus are incubated with different concentrations of the ameba. In a 96-well plate, 500 spores of B. cinerea are contacted with 5 E 02 5 and E 04 amoebae per well in a final volume of 50μ1. The amoeba tested are prepared in culture medium (CM).The following controls are also prepared under the same conditions: - B. cinerea spores in a liquid culture medium YBA- Spores of B. cinerea in culture medium (CM)- Spores of B. cinerea with the inhibitor fungicide breathingEach condition was tested in triplicate. The plates are incubated in darkness at 21 ° C for 24H or 48H. Conidial germination of B. cinerea was observed under inverted microscope and a series of pictures is performed for each condition.Results and Conclusion: The observation of spores after 24 hours allowed to highlight a slowing germination of the fungus with high concentration of amoebae. Regardless of the strain of B. cinerea, this effect is much more visible when the poppet is in contact with amounts of amoebae forming a confluent carpet (Figure 2). With lower ratios (500 amoebae) the effect is less visible compared to controls (Figure 1 and Figure 2). Strain B05.10 is a collection of strain and is less vigorous / perennial. Compared to wild strains (collected in the field), it will take longer to develop. The culture medium (TM) alone did not affect the growth of the fungus, the culture medium seems even stimulate the germination of spores of B. cinerea (Figure 3).These results show an efficiency of Willaertia magna on the germination of B. cinerea under the experimental conditions, with a qualitative dose effect observed.Example 3: Effectiveness of Willaertia masna on vine downy mildew (P. viticola):Principle: The tests are performed on seedlings of Cabernet Sauvignon. Each group of plants is treated under controlled conditions with a handle sprayer. After treatment the plants by the solutions tested, voluntarily plant infection by the downy mildew is performed. After 7 to 10 days of incubation, the severity of the disease is evaluated to assess the effectiveness of different products in relation to the severity of disease on untreated plants.Protocol:Cabernet sauvignon plants cuttings are produced in a greenhouse (temperature 15 ° C - 30 ° C) and 6 groups of 6 plants are established for the study of each test condition.Willaertia magna cells are cultured in a culture medium until the desired concentration of 9E + 09 cells per liter.Various samples were tested:1. Negative control, condition 1: no treatment.2. Environmental control, condition 2: dilution medium3. Fungicide, Condition 3: Willaertia magna in culture medium4. Fungicide, Condition 4: sample of the condition 3, diluted in dilution medium5. A fungicide Condition 5: a sample of the condition 3 is stressed mechanically to kill cells Willaertia. The sample is passed under pressure into a vacuum valve pushed almost closed with the aid of a pump, causing the death of a portion of the cells and lysis of part of the dead cells. The resulting sample is observed under a microscope, with a marker for non-viability (Trypan blue) for counting the remaining living cells (unmarked Trypan Blue)6. A fungicide Condition 6: A sample of condition 4 is stressed mechanically to kill cells Willaertia. The sample is passed under pressure into a vacuum valve pushed almost closed with the aid of a pump, causing the death of a portion of the cells and lysis of part of the dead cells. The resulting sample is observed under a microscope, with a marker for non-viability (Trypan blue) for counting the remaining living cells (unmarked Trypan Blue)7. Positive Control, Condition 6: Bordeaux mixture equivalent to 3 kg / ha.Each sample is applied to one group of six spray plants on the whole plant.After 24 hours, a sporangia suspension of P. viticola was sprayed onto the lower leaf surface. The plants are then placed in incubation at 24 ± 5 ​​° C, lit 14 hours a day, in individual rooms in a favorable moisture disease development. After 7 to 10 days, an evaluation of the fungicidal effectiveness in each condition is made, for each plant and leaf stage. Assessment is based on visual observations of fungal lesion consists of two elements: the infected area and the intensity of the sporulation. A 0 to 100% scale (in steps of 5%) is used; each sheet being observed individually. The efficacy is calculated using the following formula: Efficiency = 100 x [(T-NT) / NT] (where T is the rate of medium attack on untreated plants T and the average rate of attack on the treated plants). The results are presented in Table 2.Table 2: Conditions for testing and efficacy resultsResults and Conclusion: The severity of the disease is high (56.3%) of the untreated plants. This value is also high (55%) after spraying the dilution medium.A very small amount of disease is observed on the treated plants with Willaertia magna live form: infection by P. viticola is 2.5 to 1.3% of the leaf surface (versus 56% for the negative control untreated). An efficiency of over 95%, close to the efficiency of the reference fungicide (Bordeaux mixture to 3 kg / ha) which allows a perfect control of downy mildew with a 100% efficiency (no mildew attack ).A small amount of disease is observed on the plants treated with Willaertia magna in dead form, inactivated by the action by passage through mechanical pump and a vacuum valve pushed: infection by P. viticola is from 30% to only 1, 3% of the leaf surface (versus 56% for the untreated negative control).In conclusion, Willaertia magna live form and under dead form, provides high activity against downy mildew under the experimental conditions.

Claims

WE CLAIMSUse non-therapeutic protozoa of the species Willaertia magna, as fungistatic and / or fungicidal.Use according to Claim 1, characterized in that protozoan species Willaertia magna are used either in a live form, or in dead form, either as a cell lysate, or in admixture of living forms, and / or dead forms and / or cell lysate.Use according to one of claims 1 to 2, characterized in that protozoan species Willaertia magna are used in combination with other protozoa, e.g. amoebic protozoa of the genus Solumitris, cercozoaires of protozoa of the genus or Cercomonas cercozoaires protozoa of the genus Paracercomonas.Use according to one of claims 1 to 3, for controlling (i) against a fungus selected from the division of the Ascomycetes, more preferably from the class of Sordariomycetes, eurotiomycetes, Dothideomycetes, Saccharomycetes, Leotiomycetes, oomycetes and a combination thereof , even more preferably from the genus Botrytis, Erysiphe, Fusarium, Penicillium, Plasmopara, Phytophthora, Chaetomium, Trichoderma, Aspergillus, Alternaria, Candida, Ulocladium, Epicoccum, Cladosporium and a combination thereof, and / or (ii) fight against a fungus selected from B. cinerea, E. necator, F. solani, C. globosum, P. chrysogenum, P. viticola, P. infestans, T. viride, T. harzianum, A. fumigatus, A.alternata, A. flavus, P. variotii, A.niger, C.albicans, U. botrytis, E. nigrum, B. cinerea, P. roqueforti, C.cladosporioides, E. chevalieri, A. pullulans and a combination thereof.Use according to one of claims 1 to 4, characterized in that these correspond protozoa, the strain deposited under number PTA-7824 with the ATCC or the strain deposited under number PTA-7825 with the ATCC.

6. Use according to one of claims 1 to 5, to fight against the proliferation of plant pathogenic fungi.Use according to claim 6 for the treatment of fungal diseases of grapevine, cereals, potatoes, fruit trees and vegetable crops, especially for the treatment of fungal diseases selected from powdery mildew of the vine, downy mildew, septoria and Fusarium on cereals Phelminthosporiose cereal mildew and early blight of potato, apple scab, Sclerotinia rape and vegetable crops, and a combination thereof.(I) for disinfecting air conditioning systems of networks,(Ii) to fight against fungal contaminations and / or the formation of fungal slimes in food, processing equipment / food production, processing plants / production of foodstuffs or cosmetic products, the surfaces coming into contact with foodstuffs or cosmetics or,(Iii) for the treatment of contamination of indoor environments.

9. protozoa of the species Willaertia magna for use as a drug antifungal.

10. protozoa of the species Willaertia magna for use according to claim 9 for the treatment of infections caused by fungi selected from Aspergillus, Candida, U. botrytis, A.niger, P.variotii, A.alternata, resistant fungi the antifungal, and a combination of these.

11. protozoan species Willaertia magna for use according to claim 9 or 10 for the treatment of infections caused by the fungus Candida albicans.

12. A pharmaceutical or plant protection composition comprising protozoan species Willaertia magna and one or more formulating agents, in particular water (H 2 0), and optionally, one or more adjuvants.

13. A pharmaceutical or plant protection composition according to claim 12, in that the protozoa of the species Willaertia magna are in dead form and / or as a cell lysate, or in admixture of living form, and / or dead form and / or cell lysate.

14. A pharmaceutical or plant protection composition according to one of claims 12 to 13 which is a plant protection composition concentrated in solid dry form, in powder form, granular, in paste form or in liquid form.

15. plant protection composition according to one of claims 12 to 13 which is a plant protection composition ready for use in solid dry form, in powder form, granular, in paste form or in liquid form.